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Incidence rate of congenital 
scoliosis estimated 
from a nationwide health insurance 
database
Ji‑Won Kwon3,4,7, Hyun Wook Chae1,7, Hye Sun Lee2, Sinae Kim2, Sahyun Sung3,6, 
Soo Bin Lee3,5, Seong‑Hwan Moon3, Hwan‑Mo Lee3 & Byung Ho Lee3*
To investigate the epidemiology of congenital scoliosis (CS) and treatment trends. An age‑matched, 
nationwide, population‑based study was conducted using the National Health Insurance and Health 
Insurance Review and Assessment databases from 2010 to 2015. Data regarding the diagnosis and 
treatment of scoliosis were extracted using International Classifications of Diseases, 10th revision 
codes. The age‑matched normal population was determined from the Korean Statistical Information 
Service database. We analyzed the incidence rate of CS according to age and sex, as well as the 
proportion of surgically treated patients. A total of 1664 patients (aged 0–19 years) were diagnosed 
with CS. The overall average incidence rate of CS over the 5‑year period was 3.08 per 100,000 
persons, with the highest and second highest rates at 0 years and 12–16 years of age, respectively. 
The incidence rate stratified by age ranged from 1.5 to 20.1 per 100,000 persons among the age‑
matched normal population, with peaks at 0 years of age and the second growth spurt in adolescence 
(12–16 years for males; 10–14 years for females). Anterior surgery was rarely performed; posterior 
surgery was performed in 92 patients (5.5% of all patients), with the highest prevalence (56.5%) in 
patients diagnosed at 10–14 years of age. The overall average incidence rate of CS over a 5‑year period 
was 3.08 per 100,000 persons. Only 5.5% of patients underwent surgery within 5 years after the initial 
diagnosis.
Congenital scoliosis (CS) is a spinal malformation resulting in longitudinal and rotational imbalances due to het-
erotopic vertebra and rib bone  formation1. CS very often has accompanying anomalies, known as VACTERL asso-
ciation-type  anomalies2. VACTERL association-type anomalies refer to the co-occurrence of vertebral defects, 
anal closure, cardiac defects, tracheoesophageal fistula, renal abnormalities, and limb abnormalities. To date, 
numerous reports exist regarding the surgical outcomes of CS associated with specific VACTERL association-type 
 anomalies3–5. However, because CS has a heterogenetic and sporadic nature, causal and statistical approaches for 
determining the definite etiology and incidence rate are difficult to implement. Therefore, demographic studies 
on CS with statistical data are scarce.
The purpose of the present study is to investigate the incidence rate of CS among the age-matched normal 
population in Korea, as well as the features of CS treatment, by utilizing the National Health Insurance Service 
and Health Insurance Review and Assessment service (NHIS-HIRA) database.
Materials and methods
Data collection. The National Health Insurance (NHI) in the Republic of Korea is a public medical insur-
ance system, covering the entire Korean population. All medical institutions, including private clinics, gen-
eral hospitals attached to medical colleges, and higher-level hospitals, require NHI services to pay for medical 
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expenses. After the HIRA reviews a claim, the NHI Service refunds the medical fee to the medical institution. 
As HIRA data are obtained from a billing form that is generated for each inpatient or outpatient visit to a medi-
cal facility, it is essential for the healthcare facility to enter the correct code associated with each diagnosis and 
prescription to receive the proper refund. Thus, this database, registered as the NHIS-HIRA database, contains 
detailed data on patient demographics, diagnoses, procedures, and prescription drugs, covering all citizens of 
South Korea.
In the present study, we examined NHIS-HIRA data from January 1, 2010 to December 31, 2015. The data 
were filtered to determine the population with any type of scoliosis. We extracted only payment claims in which 
the main or secondary cause of the visit was scoliosis, as defined by the International Classification of Diseases, 
10th revision (CS: Q76.4, Q76.3) (Fig. 1). All enrollees with these codes were confirmed by orthopedic surgeons 
or a pediatrician, the authors of this study. For the incidence estimates, the date of the earliest claim with the 
registration code for congenital scoliosis was defined as the index date. To eliminate any redundant potential 
pre-existing cases of congenital scoliosis, we established a 1-year wash-out period by excluding cases identified 
in the first 1 year (2010–2011). Therefore, patients first diagnosed with congenital scoliosis from 2011 to 2015 
were included in the incidence estimates.
Additionally, we used Korean Statistical Information Service (KOSIS; http://kosis .kr) data to determine the 
total population according to age during the study period, allowing the calculation of sex-specific and age-
matched annual incidence rates (Fig. 2). This study was approved by our Institutional Review Board and Ethics 
Committee (Yonsei University Institutional Review Board and Ethics Committee: approval #2018-0062-001), 
which issued a waiver regarding the need for informed consent. All methods were performed in accordance 
with relevant guidelines and regulations.
Calculation of the incidence rate of congenital scoliosis. The distribution of the population diag-
nosed with CS was determined overall and by sex and age (from 0 to 19 years of age). Data regarding sex and age 
at the initial diagnosis of CS (the time at which the code for CS was first registered in the NHIS-HIRA database) 
Figure 1.  Diagram of the present nationwide scoliosis investigation of HIRA and NHI data. Cases of congenital 
scoliosis (defined as ICD-10th revision, Q76.4, Q76.3) were extracted from the NHIS-HIRA database (2010–
2015). ICD-10th; International Classification of Diseases, 10th revision, HIRA; Health Insurance Review and 
Assessment Service, NHI; National Health Insurance, NHIS; National Health Insurance Service.
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were collected and, using 1 and 5 year-age intervals, the sex- and age-specific incidence rates were calculated 
using the following formula:
Incidence rates are reported in terms of the number per 100,000 persons in the age- and sex-matched nor-
mal population during a given period. A chi-square test was used to compare and analyze the average of the 
incidence rate per 100,000 between the period of 2nd growth spurt (male: 12 ~ 16 years, female: 10 ~ 14 years) 
and the period except 1st and 2nd growth spurt (male: 1 ~ 11 and 17 ~ 19 years, female: 1 ~ 9 and 15 ~ 19 years). 
The p value < 0.05 was considered statistically significant. 95% confidence intervals of each incidence rates are 
also presented.
Proportion of patients who underwent surgical treatment for congenital scoliosis. We evalu-
ated the proportion of patients who underwent surgical treatment (N0444, N0445 for anterior surgery; N0446, 
N0447 for posterior surgery) between 2011 and 2015 among those initially registered and followed-up in the 
NHIS-HIRA database during the study period. The overall proportion of surgical treatment and the proportion 
of anterior and posterior surgical treatment were evaluated.
Results
Incidence rate of congenital scoliosis. The total number of patients who were initially diagnosed with 
CS between 2011 and 2015 was 1664 (895 males and 769 females). The overall average incidence rate of CS over 
the 5-year study period was 3.08 per 100,000 persons. Stratified by sex, the average incidence rate of CS over the 
5-year period was 2.99 per 100,000 persons in females and 3.18 per 100,000 persons in males. Among the 1664 
patients with CS, 905 (54.4%) were diagnosed during the years in which growth spurts occur (age: 0 year and 
12–16 years for males, 0 year and 10–14 years for females). Furthermore, 234 males and 211 females (26.1% and 
27.4%) were diagnosed with CS during the second set of growth spurt years (in adolescence) (Table 1, Fig. 3).
Stratified by age, the overall average incidence rate of CS over the 5-year period ranged from 1.5 to 20.1 
per 100,000 persons. The highest incidence rate was observed at 0 years of age, and followed a parabolic shape, 
pointing downward, with a second incidence rate peak at 12–16 years of age. Further stratified by sex, the aver-
age incidence rate of CS over the 5-year period ranged from 1.2 to 20.4 per 100,000 persons in males and from 
1.1 to 19.8 per 100,000 persons in females.
As a result of comparing the overall data including incidence rate per 100,000 people between 2nd growth 
spurt period (Male: 12–16 years, Female: 10–14 years) and except growth spurt period, from 2011 to 2015, there 
were significant differences as p = 0.001 for male and p < 0.001 for female (Fig. 4).
Number of diagnosed patients/number of individuals in the age - matched normal population
Figure 2.  The population distribution by age group in 2010 in South Korea, based on Korean Statistical 
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For males, the highest incidence rate was observed at 0 years of age (20.4 per 100,000 persons), followed by 
that at 15 years of age (3.65 per 100,000 persons). For females, the highest incidence rate was observed at 0 years 
of age (19.8 per 100,000 persons), followed by that at 13 years of age (4.0 per 100,000 persons). Thus, the high-
est incidence rate occurred at 0 years of age in both males and females, but the second highest incidence rate 
occurred approximately 2 years later in males than in females (Tables 2, 3, Fig. 3).
Proportion of patients who underwent surgical treatment. A total of 92 (5.5%) patients diagnosed 
with CS during the study period underwent surgery within 5 years after the initial diagnosis. Among these, 14 
patients were diagnosed at 15–19 years of age (9 males and 5 females), 52 patients (56.5%) were diagnosed at 
10–14 years of age (25 males and 27 females), 15 were diagnosed at 5–9 years of age (5 males and 10 females); 
and 11 patients (12.0%) were diagnosed at 0–4 years of age (4 males and 7 females). In total, 57 of the surgical 
cases were male and 75 were female; the difference between the sexes failed to reach significance (p = 0.163).
Anterior surgery (N0444, N0445) was performed in only 3 patients (0.18% of all patients with CS and 3.26% of 
surgically treated patients with CS). In contrast, posterior surgery (N0446, N0447) was performed in 92 patients 
(5.5% of all patients with CS). 11 patients (12.0%) diagnosed at 0–4 years of age, 15 (16.3%) patients diagnosed 
at 5–9 years of age, 52 (56.5%) patients diagnosed at 10–14 years of age, and 14 (15.2%) patients diagnosed at 
15–19 years of age underwent posterior surgery. Thus, most surgical interventions comprised posterior surgery, 
with the highest prevalence (56.5%) in patients diagnosed with CS at 10–14 years of age (Fig. 5).
Discussion
This study is the first population-based epidemiological study on CS in the Republic of Korea, which has a 
population of approximately 50 million. Due to its rarity, little is known about the incidence rate of CS. Previous 
studies have reported that congenital spinal malformations occur at a frequency of 0.01–1.0 per 1000 live births, 
accounting for about 8.9% of all structural scoliosis cases, and are 2.5 times more prevalent in  females6–8. How-
ever, in the present study, the 5-year average incidence rate was 3.08 per 100,000 persons, with a slightly higher 
rate in male than in females. Recently, von Heideken et al. reported an overall annual incidence rate of CS of 0.7 
per 100,000 persons using a Swedish nationwide  sampling8. However, as this previous nationwide study focused 
on patients who underwent surgical treatment in Sweden, it is not surprising that the incidence was much lower 
than that in the present study, which focused on those diagnosed with CS among the total population.
Additionally, Passias et al., using data from the Healthcare Cost and Utilization Project’s Kids Inpatient Data-
base (KID) in the United States, reported that the incidences of the congenital spinal abnormalities, hemivertebra 
and the absence of vertebra, were 9.1 and 1.2 per 100,000 persons, respectively, which differ from those in the 
present  report9. The study by Passias et al. focused on VACTERL syndrome associated with congenital spinal 
abnormalities; thus, the difference in study results might be related to the use of different codes for reimburse-
ment in the International Classification of Disease, Ninth Revision, and Clinical Modification (ICD-9-CM) 
formats.
The shape and extent of spinal deformities in patients with congenital spinal malformations vary  greatly6,10. 
Although many patients do not experience spinal deformities or imbalance problems during their lifetime, early 
deformities can result in problems, such as cardiopulmonary decline and spinal cord  compression11,12. Consid-
ering the diversity in the natural course of CS, numerous studies have focused on the prediction of the natural 
course in patients with  CS2,13,14. However, the prediction accuracy has not yet reached a satisfactory level, and 
trends in the initial patient incidence rate between the ages of 0–19 years have not been considered.
Moreover, CS is a congenital anomaly of the spine associated with abnormalities inside and outside of the 
 spine10,15–17. VACTERL syndrome usually involves 3 or more previous VACTERL association-type anomalies. 
Therefore, it is expected that the highest incidence rate of CS would be observed in newborns with symptoms 
related to VACTERL association-type abnormalities. Furthermore, CS is often clinically significant at the time 
of the first growth spurt, as the patient’s growth pattern becomes noticeably below normal threshold  values2,10. 
Subsequently, the scoliotic angle progresses during the second growth spurt period, which is associated with 
longitudinal and volumetric growth, potentially leading to an increase in the diagnosis of  CS14.
The age- and sex-specific incidence rates showed a characteristic downward-pointing parabolic shape in 
the present study, with two peaks at 0 years and 12–16 years of age. Previous studies have reported that spinal 
deformities, usually caused by congenital vertebral malformations, tend to progress rapidly during infancy and 
pre-adolescent growth spurts, and tend to be relatively slow during mid-childhood (5–10 years of age)2,8,10. This 
Table 1.  Individual annual and 5-years average incidence rate of congenital scoliosis from 2011 to 2015.
Year
Total population (0 ~ 19 years old)
Congenital scoliosis 
patients (0 ~ 19 years old) Incidence rate per 100,000
Overall Male Female Overall Male Female Overall Male Female
2011 11,239,996 5,881,170 5,358,826 441 237 204 3.92 4.03 3.81
2012 11,012,807 5,753,390 5,259,417 365 203 162 3.31 3.53 3.08
2013 10,765,287 5,611,677 5,153,610 320 161 159 2.97 2.87 3.09
2014 10,503,422 5,461,478 5,041,944 248 148 100 2.36 2.71 1.98
2015 10,252,151 5,317,005 4,935,146 290 146 144 2.83 2.75 2.92
5-years average 3.08 3.18 2.99
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Figure 3.  Sex-specific incidence rate of congenital scoliosis based on age (0–19 years), from 2011 to 2015: (A) 
Overall (female + males), (B) Males, and (C) Females. X-axis; age in years, Y-axis; incidence rate per 100,000. 
95% confidence intervals are also indicated.
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pattern in progression is thought to exist because spinal deformities result from an imbalance in spinal length 
growth (due to an unbalanced distribution of the superior and inferior endplates), stemming from congenital 
malformations. This conception is consistent with the results of the present study. According to a report of 250 
congenital scoliosis patients conducted by McMaster et al., the bimodal pattern showed the highest incidence 
rate in the 1st growth spurt period, followed by the second highest incidence rate in the 2nd growth spurt period. 
Showed. Although this study was a total survey of approximately 50 million people, the results were similar to 
the above. Therefore, it can have a clinical meaning to recognize that congenital scoliosis can be diagnosed even 
in adolescence.
Additionally, in the present study, the second peak in the incidence rate of CS occurred about 2 years earlier 
in females than in males, consistent with the fact that the second growth spurt occurs approximately 2 years 
earlier in females than in  males18,19. This difference in growth spurt tendency may also influence the number of 
times that patients with CS visit a medical facility owing to symptoms, such as those associated with VACTERL 
anomalies, CS-related symptoms, and pain due to scoliosis angle progression.
The treatment of the spinal deformities due to congenital vertebral malformations remains the domain with 
the most room for development. Ideally, spinal deformities and other congenital abnormalities should be treated 
early, and the natural course of the spinal deformity should be predicted in advance to avoid spinal deformity 
advancement and secondary deformities. However, unlike in adolescent idiopathic scoliosis, a quantitative Cobb 
angle for the recommendation of surgical treatment has not been  established20–22. Therefore, it is essential to 
closely observe the progression of the lesion, as this is the most important factor determining the need for surgical 
treatment. Information regarding the type of surgical treatment performed, and the age at which it is performed, 
will be helpful in understanding the appropriate treatment of the lesion. The age at the time of surgery varies 
depending on the surgical conditions and settings. Surgery performed at an appropriate age, when there is less 
impairment in pulmonary function, can lead to better surgical  outcomes8,20.
The present study provides new information regarding the latest trends in the surgical treatment of CS. The 
surgery rate was the highest (56.5% of all surgical cases) among the patients who were diagnosed at an age of 
Figure 4.  Comparison of Age-specific incidence rate between 2nd growth spurt period (Male: 12–16 years, 
Female: 10–14 years) and except growth spurt period, from 2011 to 2015: (A) Males, and (B) Females. X-axis; 
age in years, Y-axis; incidence rate per 100,000. 95% confidence intervals are also indicated. * means that the two 
groups are statistically significantly different.
7
Vol.:(0123456789)
Scientific Reports |         (2021) 11:5507  | https://doi.org/10.1038/s41598-021-85088-7
www.nature.com/scientificreports/
Table 2.  Sex-specific and age-specific annual incidence rate of congenital scoliosis for 5 years (2011–2015). 
*Annual incidences are represented in terms of the number per 100,000 persons. *Korean Statistical 
Information Service (KOSIS; http://kosis .kr) data was used to determine the total population according to age 
during the study period, allowing the calculation of sex-specific and age-matched annual incidences.
Year
2011 2012 2013 2014 2015
Overall Male Female Overall Male Female Overall Male Female Overall Male Female Overall Male Female
Age
0 18.64 20.93 16.22 15.82 18.44 13.04 20.01 14.68 25.62 21.52 25.45 17.38 24.45 22.52 26.49
1 4.50 4.37 4.65 2.91 4.45 1.29 4.66 4.12 5.24 2.37 2.52 2.21 3.68 3.14 4.25
2 2.88 1.72 4.12 2.03 2.19 1.86 2.50 4.05 0.86 1.91 2.47 1.31 2.38 1.26 3.55
3 2.28 2.81 1.71 1.78 1.72 1.83 2.03 3.06 0.93 0.83 0.00 1.72 1.70 2.48 0.87
4 3.30 3.41 3.18 2.07 1.61 2.56 1.34 0.86 1.84 1.58 2.63 0.47 1.88 1.22 2.57
5 3.00 4.45 1.44 1.32 1.28 1.37 1.66 2.01 1.29 1.78 0.86 2.76 0.90 0.88 0.93
6 2.04 1.75 2.35 1.85 1.34 2.40 0.66 0.86 0.46 1.46 1.21 1.72 1.79 0.87 2.77
7 2.74 3.65 1.76 2.49 3.06 1.88 1.39 1.34 1.44 0.44 0.43 0.46 1.04 0.81 1.29
8 0.42 0.40 0.44 2.74 2.84 2.63 1.59 1.75 1.41 1.16 0.89 1.44 2.22 2.58 1.83
9 1.57 0.75 2.46 2.52 2.02 3.07 1.90 1.22 2.64 1.59 2.19 0.94 1.86 2.24 1.45
10 4.05 2.91 5.30 1.96 1.13 2.87 1.68 1.62 1.76 1.27 1.22 1.32 2.28 1.76 2.83
11 2.61 2.18 3.07 3.38 2.92 3.89 4.12 3.76 4.51 1.47 2.43 0.44 0.64 0.41 0.88
12 5.57 4.68 6.55 4.06 3.42 4.77 1.86 1.29 2.47 1.96 2.63 1.23 1.89 1.62 2.20
13 6.08 6.29 5.85 4.26 4.06 4.48 2.76 2.80 2.72 1.86 1.29 2.47 3.33 2.25 4.51
14 4.08 3.47 4.76 3.43 3.60 3.25 2.30 2.50 2.07 1.14 0.93 1.36 1.01 1.29 0.71
15 3.22 3.88 2.49 4.39 5.21 3.49 3.43 4.50 2.27 1.64 1.57 1.72 2.11 3.11 1.02
16 3.65 3.01 4.38 2.79 1.94 3.74 2.27 1.45 3.17 2.18 3.30 0.97 1.81 1.57 2.07
17 1.73 1.89 1.54 1.31 1.64 0.94 1.90 1.38 2.49 1.36 1.74 0.95 1.24 1.79 0.65
18 3.68 4.53 2.73 2.87 3.77 1.84 1.74 3.00 0.31 1.17 1.38 0.93 1.96 3.18 0.63
19 3.14 4.59 1.51 2.67 4.23 0.90 1.71 2.41 0.92 1.74 2.71 0.62 1.88 2.19 1.53
Table 3.  Sex-specific and age-specific average incidence rate of congenital scoliosis for 5 years (2011–2015). 
*Annual incidences are represented in terms of the number per 100,000 persons. *Korean Statistical 
Information Service (KOSIS; http://kosis .kr) data was used to determine the total population according to age 
during the study period, allowing the calculation of sex-specific and age-matched annual incidences. *95% CI 
indicates 95% confidence interval.
Year
Overall Male Female
95% CI Lower limit Average 95% CI Upper limit 95% CI Lower limit Average 95% CI Upper limit 95% CI Lower limit Average 95% CI Upper limit
Age
0 17.27 20.09 22.91 16.82 20.40 23.98 14.51 19.75 24.99
1 2.76 3.63 4.49 2.98 3.72 4.46 2.04 3.53 5.01
2 2.00 2.34 2.68 1.41 2.34 3.27 1.09 2.34 3.59
3 1.24 1.72 2.20 0.93 2.01 3.10 1.00 1.41 1.82
4 1.36 2.03 2.70 1.02 1.95 2.87 1.21 2.12 3.04
5 1.05 1.73 2.42 0.58 1.90 3.21 0.94 1.56 2.17
6 1.08 1.56 2.03 0.88 1.20 1.53 1.14 1.94 2.73
7 0.77 1.62 2.47 0.61 1.86 3.10 0.87 1.36 1.86
8 0.83 1.63 2.42 0.77 1.69 2.62 0.86 1.55 2.25
9 1.55 1.89 2.23 1.10 1.68 2.27 1.34 2.11 2.89
10 1.31 2.25 3.19 1.10 1.73 2.35 1.46 2.82 4.17
11 1.21 2.44 3.68 1.25 2.34 3.42 0.97 2.56 4.15
12 1.59 3.07 4.54 1.52 2.73 3.94 1.54 3.44 5.34
13 2.24 3.66 5.07 1.65 3.34 5.03 2.77 4.01 5.24
14 1.20 2.39 3.58 1.29 2.36 3.43 1.02 2.43 3.84
15 2.00 2.96 3.92 2.43 3.65 4.88 1.39 2.20 3.00
16 1.92 2.54 3.16 1.51 2.25 2.99 1.68 2.87 4.05
17 1.26 1.51 1.76 1.52 1.69 1.86 0.67 1.31 1.95
18 1.41 2.28 3.16 2.15 3.17 4.19 0.42 1.29 2.15
19 1.66 2.23 2.79 2.26 3.23 4.19 0.74 1.10 1.45
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10–14 years. Furthermore, the noticeable difference in frequencies of anterior and posterior surgeries is a reflec-
tion of the advancement in methods that are only used in posterior surgery for the treatment of  CS4,23.
This study has several limitations. First, the most commonly used classification system for CS is the modified 
method of McMaster and  Ohtsuka2. This system classifies CS into a formation defect, segmentation defect, or 
complex malformation, according to the mechanism of development. However, detailed incidence rates of CS 
subtypes, as well the most vulnerable type of surgical treatment implementation, could not be determined in 
the present study.
Second, to determine the proportion of patients with CS who underwent surgical treatment, we extracted 
claims using the code for anterior surgery (N0444, N0445) or posterior surgery (N0446, N0447) from the 
NHIS-HIRA database. CS is closely related to the development of the spinal mesoderm, and it is known that 
61% of patients with CS have congenital malformations of other types occurring in the mesoderm. As the code 
for surgical treatment owing to the expression of VACTERL-association syndromes was an exclusion criterion, 
the data of patients with CS who underwent surgical treatment for extraspinal anomalies were not included in 
the surgical treatment analysis. In addition, growing rod instrumentation and vertical expandable prosthetic 
titanium ribs (VEPTR) have emerged as treatments for patients with spinal deformities aged over 5 years, while 
maintaining growth, and surgical treatments to inhibit progression have been  developed3,24,25. Currently, there 
are no surgical codes associated with VEPTR surgeries in the NHIS-HIRA system, and we cannot assume that 
VEPTR surgeries were included in the posterior surgery code.
Third, since the modified classification of CS according to McMaster and Ohtsuka cannot be classified accord-
ing to the NHIS-HIRA database, there is a risk of missing congenital malformation of spine that did not progress 
at the time of diagnosis. For this, Q76.3, which is a non-billable code and codes for the congenital malformation 
of spine, in which the scoliotic angle did not progress at the time of diagnosis, was included. As a result, the 
proposed result may be over-estimation or underestimated, resulting in a limitation that must be interpreted 
carefully.
Figure 5.  Diagrams showing the proportion of patients with CS who underwent surgical treatment: (A) 
Posterior surgical treatment, and (B) Anterior surgical treatment. Data were extracted through the following 
procedure codes (N0444, N0445 for anterior surgery; N0446, N0447 for posterior surgery), from 2011 to 
2015. Patients corresponding to ‘Yes’ are separately stratified according to age, and the patterns of patients who 
received surgical treatment are further described according to age group. N (n%): N, Number of age-stratified 
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Conclusion
In conclusion, the present Korean epidemiological study on CS, the first of its kind, estimated the average inci-
dence rate of CS over a 5-year period (2011 to 2015) as 3.08 per 100,000 persons. The age-specific CS incidence 
rate was highest at 0 years of age, and showed a downward-pointing parabolic shape, with a second peak during 
adolescence, at the time of the second growth spurt. Additionally, only 5.5% of patients with CS underwent 
surgery within 5 years of the initial diagnosis.
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